BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32471703)

  • 1. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room.
    Assandri R; Buscarini E; Canetta C; Scartabellati A; Viganò G; Montanelli A
    Arch Med Res; 2020 Aug; 51(6):598-599. PubMed ID: 32471703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.
    Kurstjens S; van der Horst A; Herpers R; Geerits MWL; Kluiters-de Hingh YCM; Göttgens EL; Blaauw MJT; Thelen MHM; Elisen MGLM; Kusters R
    Clin Chem Lab Med; 2020 Aug; 58(9):1587-1593. PubMed ID: 32598302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hematological parameters in COVID-19 patients in the emergency room.
    Usul E; Şan İ; Bekgöz B; Şahin A
    Biomark Med; 2020 Sep; 14(13):1207-1215. PubMed ID: 32692248
    [No Abstract]   [Full Text] [Related]  

  • 4. Mild versus severe COVID-19: Laboratory markers.
    Velavan TP; Meyer CG
    Int J Infect Dis; 2020 Jun; 95():304-307. PubMed ID: 32344011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data.
    Gatti M; Calandri M; Barba M; Biondo A; Geninatti C; Gentile S; Greco M; Morrone V; Piatti C; Santonocito A; Varello S; Bergamasco L; Cavallo R; Di Stefano R; Riccardini F; Boccuzzi A; Limerutti G; Veltri A; Fonio P; Faletti R
    Radiol Med; 2020 Dec; 125(12):1271-1279. PubMed ID: 32894449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging key laboratory tests for patients with COVID-19.
    Kavsak PA; de Wit K; Worster A
    Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
    [No Abstract]   [Full Text] [Related]  

  • 8. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Researchers Home in on COVID-19 Severity Biomarkers.
    Abbasi J
    JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
    [No Abstract]   [Full Text] [Related]  

  • 10. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
    Poggiali E; Zaino D; Immovilli P; Rovero L; Losi G; Dacrema A; Nuccetelli M; Vadacca GB; Guidetti D; Vercelli A; Magnacavallo A; Bernardini S; Terracciano C
    Clin Chim Acta; 2020 Oct; 509():135-138. PubMed ID: 32531257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cautious interpretation of antiphospholipid antibodies in COVID-19.
    Mehta S; Bhandari S; Mehta S
    Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin-6 as a potential biomarker of COVID-19 progression.
    Ulhaq ZS; Soraya GV
    Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine blood tests as a potential diagnostic tool for COVID-19.
    Ferrari D; Motta A; Strollo M; Banfi G; Locatelli M
    Clin Chem Lab Med; 2020 Jun; 58(7):1095-1099. PubMed ID: 32301746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department].
    Pascual Gómez NF; Monge Lobo I; Granero Cremades I; Figuerola Tejerina A; Ramasco Rueda F; von Wernitz Teleki A; Arrabal Campos FM; Sanz de Benito MA
    Rev Esp Quimioter; 2020 Aug; 33(4):267-273. PubMed ID: 32657550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
    Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.